Araştırma Makalesi

Detection of CAG trinucleotide repeat numbers with fragment analysis in patients diagnosed with Huntington’s disease and in their families

Cilt: 44 Sayı: 2 30 Haziran 2019
Davut Alptekin *, Perçin Pazarcı , Mehmet Ali Bereketoğlu , Mehmet Ali Erkoç , Nermin Seda Ilgaz , Ümit Lüleyap
PDF İndir
TR EN

Detection of CAG trinucleotide repeat numbers with fragment analysis in patients diagnosed with Huntington’s disease and in their families

Abstract

Purpose: Huntington's Disease (HD) is an autosomal dominant disorder affecting nervous system. CAG trinucleotide repeat (TNR) increase in Huntingtin gene causes the disease. In normal individuals, 10-35 TNRs are found whereas in HD this number exceeds 36-37. This study aimed to investigate TNR numbers in individuals with HD diagnosed family and to provide genetic counselling for individuals with abnormal alleles.

Materials and Methods: Subjects consist of family members of a male who died at age of 60 due to HD. Randomly selected 57 healthy individuals are also analysed for control. TNR numbers were determined by fragment analysis.

Results: TNR numbers of family members were determined as 17, 21, 23, 25, 33, 36 and 39. TNR numbers of randomly selected healthy people were found below 26. Individuals with 33 and 36 TNRs were considered as risk groups. Individuals with 39 TNRs were considered as HD patients.

Conclusion: Since some subjects had 39 TNRs, it was emphasized that these people should be under physician control. Prenatal diagnosis is recommended to those who plan to have children. In addition, subjects with 33 and 36 CAG trinucleotide repeats are advised to inform new generations about HD and that they may be affected in future.


Keywords

Huntington's disease,Huntingtin gene,Neurodegenerative diseases,Trinucleotide Repeats

Kaynakça

  1. 1. Rosenberg NK, Sorensen SA, Christensen AL. Neuropsychological characteristics of Huntington's disease carriers: a double blind study. J Med Genet. 1995; 32:600-4.
  2. 2. Lanska DJ. George Huntington (1850-1916) and hereditary chorea. J Hist Neurosci. 2000; 9:76-89.
  3. 3. Walker FO. Huntington's disease. Lancet. 2007; 369:218-28.
  4. 4. Dayalu P, Albin RL. Huntington Disease. Neurol Clin. 2015; 33:101-14.
  5. 5. Wallace DC, Hall AC. Evidence of genetic heterogeneity in Huntington's chorea. J Neurol Neurosurg Psychiatry. 1972; 35:789-800.
  6. 6. Nance MA, Myers RH. Juvenile onset Huntington's disease?clinical and research perspectives. Mental Retardation and Developmental Disabilities Research Reviews. 2001; 7:153-7.
  7. 7. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature. 1983; 306:234-8.
  8. 8. Macdonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L et al. A Novel Gene Containing a Trinucleotide Repeat That Is Expanded and Unstable on Huntingtons-Disease Chromosomes. Cell. 1993; 72:971-83.
  9. 9. Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet. 1993; 4:387-92.
  10. 10. Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet. 1993; 4:393-7.

Kaynak Göster

MLA
Alptekin, Davut, vd. “Detection of CAG trinucleotide repeat numbers with fragment analysis in patients diagnosed with Huntington’s disease and in their families”. Cukurova Medical Journal, c. 44, sy 2, Haziran 2019, ss. 517-23, doi:10.17826/cumj.461390.